HFMA response / Extension to review of subsidiary companies
The HFMA does not agree with the extension of the reporting requirement to all subsidiaries regardless of size. Instead, the materiality threshold should be revised to include other criteria which will identify high risk transactions including the establishment of subsidiaries or subsidiary companies.
Related content
Costing conference 2025
The Institute’s annual costing conference provides the NHS with the latest developments and guidance in NHS costing.
Integrated care series 2025
This webinar series offers colleagues of ICS organisations the opportunity to discuss common priorities, challenges, and successes within their field.